Biocept Company
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
Technology:
Сancer Diagnostics
Industry:
Deep Diagnostics
Headquarters:
San Diego, California, United States
Founded Date:
01.01.1993
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
3
Total Funding:
$43.2M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership